One-way ANOVA analysis was used to generate p-values in the comparison of each experimental condition with the control. A p-value of <0.05 was considered significant and <0.001, highly significant. All error bars shown are the calculated standard deviation (stdev) or standard error of the mean (SEM) across duplicate or triplicate experiments.
106
REFERENCES
1. Gupta, K., Miller, J. D., Li, J. Z., Russell, M. W., and Charbonneau, C. (2008) Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat. Rev. 34, 193-205
2. Eggener, S. E., Yossepowitch, O., Pettus, J. A., Snyder, M. E., Motzer, R. J., and Russo, P. (2006) Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 24, 3101-3106
3. Enomoto, M., Hayakawa, S., Itsukushima, S., Ren, D. Y., Matsuo, M., Tamada, K.,
Oneyama, C., Okada, M., Takumi, T., Nishita, M., and Minami, Y. (2009)
Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling. Oncogene 28, 3197-3208
4. Morioka, K., Tanikawa, C., Ochi, K., Daigo, Y., Katagiri, T., Kawano, H., Kawaguchi, H., Myoui, A., Yoshikawa, H., Naka, N., Araki, N., Kudawara, I., Ieguchi, M.,
Nakamura, K., Nakamura, Y., and Matsuda, K. (2009) Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcoma. Cancer Sci 5. O'Connell, M. P., Fiori, J. L., Xu, M., Carter, A. D., Frank, B. P., Camilli, T. C.,
French, A. D., Dissanayake, S. K., Indig, F. E., Bernier, M., Taub, D. D., Hewitt, S. M., and Weeraratna, A. T. (2009) The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma. Oncogene
6. Edris, B., Espinosa, I., Muhlenberg, T., Mikels, A., Lee, C. H., Steigen, S. E., Zhu, S., Montgomery, K. D., Lazar, A. J., Lev, D., Fletcher, J. A., Beck, A. H., West, R. B., Nusse, R., and van de Rijn, M. (2012) ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour. J. Pathol. 227, 223-233
7. Kobayashi, M., Shibuya, Y., Takeuchi, J., Murata, M., Suzuki, H., Yokoo, S., Umeda, M., Minami, Y., and Komori, T. (2009) Ror2 expression in squamous cell carcinoma and epithelial dysplasia of the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107, 398-406
8. Yamamoto, H., Oue, N., Sato, A., Hasegawa, Y., Matsubara, A., Yasui, W., and
Kikuchi, A. (2010) Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase. Oncogene 29, 2036-2046
9. Kubo, T., Kuroda, Y., Shimizu, H., Kokubu, A., Okada, N., Hosoda, F., Arai, Y., Nakamura, Y., Taniguchi, H., Yanagihara, K., Imoto, I., Inazawa, J., Hirohashi, S., and Shibata, T. (2009) Resequencing and copy number analysis of the human
107
tyrosine kinase gene family in poorly differentiated gastric cancer. Carcinogenesis 30, 1857-1864
10. Ohta, H., Aoyagi, K., Fukaya, M., Danjoh, I., Ohta, A., Isohata, N., Saeki, N., Taniguchi, H., Sakamoto, H., Shimoda, T., Tani, T., Yoshida, T., and Sasaki, H. (2009) Cross talk between hedgehog and epithelial-mesenchymal transition pathways in gastric pit cells and in diffuse-type gastric cancers. Br. J. Cancer 100, 389-398
11. Yamagata, K., Li, X., Ikegaki, S., Oneyama, C., Okada, M., Nishita, M., and Minami, Y. (2012) Dissection of Wnt5a-Ror2 signaling leading to matrix metalloproteinase (MMP-13) expression. The Journal of biological chemistry 287, 1588-1599 12. O'Connell, M. P., Fiori, J. L., Xu, M., Carter, A. D., Frank, B. P., Camilli, T. C.,
French, A. D., Dissanayake, S. K., Indig, F. E., Bernier, M., Taub, D. D., Hewitt, S. M., and Weeraratna, A. T. (2010) The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma. Oncogene 29, 34-44
13. Wright, T. M., Brannon, A. R., Gordan, J. D., Mikels, A. J., Mitchell, C., Chen, S., Espinosa, I., van de Rijn, M., Pruthi, R., Wallen, E., Edwards, L., Nusse, R., and Rathmell, W. K. (2009) Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma. Oncogene 28, 2513-2523
14. Lu, B. J., Wang, Y. Q., Wei, X. J., Rong, L. Q., Wei, D., Yan, C. M., Wang, D. J., and Sun, J. Y. (2012) Expression of WNT-5a and ROR2 correlates with disease severity in osteosarcoma. Mol Med Report 5, 1033-1036
15. Lai, S. S., Xue, B., Yang, Y., Zhao, L., Chu, C. S., Hao, J. Y., and Wen, C. J. (2012) Ror2-Src signaling in metastasis of mouse melanoma cells is inhibited by NRAGE. Cancer Genet 205, 552-562
16. Choi, H., Chun, Y. S., Kim, T. Y., and Park, J. W. (2010) HIF-2alpha enhances beta- catenin/TCF-driven transcription by interacting with beta-catenin. Cancer Res 70, 10101-10111
17. Ren, D., Minami, Y., and Nishita, M. (2011) Critical role of Wnt5a-Ror2 signaling in motility and invasiveness of carcinoma cells following Snail-mediated epithelial- mesenchymal transition. Genes Cells 16, 304-315
18. Yamamura, S., Kawakami, K., Hirata, H., Ueno, K., Saini, S., Majid, S., and Dahiya, R. (2010) Oncogenic functions of secreted Frizzled-related protein 2 in human renal cancer. Mol Cancer Ther 9, 1680-1687
108
19. Courtwright, A., Siamakpour-Reihani, S., Arbiser, J. L., Banet, N., Hilliard, E., Fried, L., Livasy, C., Ketelsen, D., Nepal, D. B., Perou, C. M., Patterson, C., and Klauber- Demore, N. (2009) Secreted frizzle-related protein 2 stimulates angiogenesis via a calcineurin/NFAT signaling pathway. Cancer Res. 69, 4621-4628
20. Edge, S. B., and Compton, C. C. (2010) The American Joint Committee on Cancer:
the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann. Surg. Oncol. 17, 1471-1474
21. Raj, G. V., Thompson, R. H., Leibovich, B. C., Blute, M. L., Russo, P., and Kattan, M. W. (2008) Preoperative nomogram predicting 12-year probability of metastatic renal cancer. J Urol 179, 2146-2151; discussion 2151
22. Flanigan, R. C., Polcari, A. J., and Hugen, C. M. (2011) Prognostic variables and nomograms for renal cell carcinoma. International journal of urology : official journal of the Japanese Urological Association 18, 20-31
23. Frank, I., Blute, M. L., Cheville, J. C., Lohse, C. M., Weaver, A. L., and Zincke, H. (2002) An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 168, 2395-2400
24. Zisman, A., Pantuck, A. J., Dorey, F., Said, J. W., Shvarts, O., Quintana, D., Gitlitz, B. J., deKernion, J. B., Figlin, R. A., and Belldegrun, A. S. (2001) Improved
prognostication of renal cell carcinoma using an integrated staging system. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19, 1649-1657
25. Motzer, R. J., Bacik, J., Murphy, B. A., Russo, P., and Mazumdar, M. (2002)
Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20, 289-296
26. Brannon, A. R., Reddy, A., Seiler, M., Arreola, A., Moore, D. T., Pruthi, R. S., Wallen, E. M., Nielsen, M. E., Liu, H., Nathanson, K. L., Ljungberg, B., Zhao, H., Brooks, J. D., Ganesan, S., Bhanot, G., and Rathmell, W. K. (2010) Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct
Subtypes and Survival Patterns. Genes Cancer 1, 152-163
27. Li, X., Yamagata, K., Nishita, M., Endo, M., Arfian, N., Rikitake, Y., Emoto, N., Hirata, K., Tanaka, Y., and Minami, Y. (2013) Activation of Wnt5a-Ror2 signaling associated with epithelial-to-mesenchymal transition of tubular epithelial cells during renal fibrosis. Genes to cells : devoted to molecular & cellular mechanisms 18, 608-619
109
28. Tusher, V. G., Tibshirani, R., and Chu, G. (2001) Significance analysis of
microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U. S. A. 98, 5116-5121
29. Rasmussen, N. R., Wright, T. M., Brooks, S. A., Hacker, K. E., Debebe, Z., Sendor, A. B., Walker, M. P., Major, M. B., Green, J., Wahl, G. M., and Rathmell, W. K. (2013) Receptor tyrosine kinase-like orphan receptor 2 (Ror2) expression creates a poised state of Wnt signaling in renal cancer. The Journal of biological chemistry 30. (2013) Comprehensive molecular characterization of clear cell renal cell carcinoma.
Nature 499, 43-49
31. Wu, B., Crampton, S. P., and Hughes, C. C. (2007) Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Immunity 26, 227- 239
32. Sonderegger, S., Haslinger, P., Sabri, A., Leisser, C., Otten, J. V., Fiala, C., and Knofler, M. (2010) Wingless (Wnt)-3A induces trophoblast migration and matrix metalloproteinase-2 secretion through canonical Wnt signaling and protein kinase B/AKT activation. Endocrinology 151, 211-220
33. Aron, M., Nguyen, M. M., Stein, R. J., and Gill, I. S. (2008) Impact of gender in renal cell carcinoma: an analysis of the SEER database. Eur. Urol. 54, 133-140
34. Teng, B. L., Hacker, K. E., Chen, S., Means, A. R., and Rathmell, W. K. (2011) Tumor suppressive activity of prolyl isomerase Pin1 in renal cell carcinoma. Mol Oncol 5, 465-474